SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001078782-20-000251
Filing Date
2020-04-15
Accepted
2020-04-15 10:30:54
Documents
56
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K ANNUAL REPORT f10k123119_10k.htm 10-K 634859
2 EXHIBIT 31.1 SECTION 906 CERTIFICATION f10k123119_ex31z1.htm EX-31.1 8354
3 EXHIBIT 32.1 SECTION 302 CERTIFICATION f10k123119_ex32z1.htm EX-32.1 3433
  Complete submission text file 0001078782-20-000251.txt   1965142

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT marz-20191231_cal.xml EX-101.CAL 19733
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT marz-20191231_def.xml EX-101.DEF 45385
6 XBRL INSTANCE DOCUMENT marz-20191231.xml EX-101.INS 181118
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT marz-20191231_lab.xml EX-101.LAB 141352
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT marz-20191231_pre.xml EX-101.PRE 120004
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT marz-20191231.xsd EX-101.SCH 26610
Mailing Address 109 AMBERSWEET WAY, #401 DAVENPORT FL 33897
Business Address 109 AMBERSWEET WAY, #401 DAVENPORT FL 33897 732-723-7395
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53223 | Film No.: 20792914
SIC: 2834 Pharmaceutical Preparations